Novavax reported $1.29B in Market Capitalization this May of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Adma Biologics USD 4.34B 845M Dec/2025
Agenus USD 107M 16M Dec/2025
AstraZeneca USD 301.25B 13.1B Mar/2026
BioCryst Pharmaceuticals USD 1.66B 64M Dec/2025
Cassava Sciences USD 96M 45M Dec/2025
Geron USD 946M 9M May/2026
GlaxoSmithKline GBP 83.8B 9.44B Mar/2026
MannKind USD 965M 208M May/2026
Merck USD 297.1B 35.84B Mar/2026
Moderna USD 20.15B 8.53B Mar/2026
Novavax USD 1.09B 316M Dec/2025
Pfizer USD 147.4B 6.42B May/2026
Sanofi EUR 100.27B 605.48M Mar/2026
Sarepta Therapeutics USD 2.16B 123M May/2026
TG Therapeutics USD 6.48B 1.18B May/2026